Same injection, same spot, every day—and that’s how you end up with lipodystrophy. Here’s the rotation pattern that protects your tissue.

Sources and References

Related Guides

Quick Facts

Table of Contents

1. Why Rotation Matters: The Tissue Cost of Skipping It
2. The Four Primary Subcutaneous Injection Zones
3. Absorption Speed and Why Timing Matters
4. Rotation Patterns: Clock Method, Grid Method, Zone-Per-Day Scheduling
5. How to Track Your Sites
6. What Lipohypertrophy Looks Like (and When to Skip)
7. Special Considerations for Multi-Injection Protocols
8. How Rotation Interacts with Peptide Timing
9. FAQ
10. Related Guides

↑ Back to top

Quick Facts

Why Rotation Matters: The Tissue Cost of Skipping It

The Four Problems with Single-Site Injections

If you inject the same spot twice a day for more than a few weeks, your tissue will tell you. The mechanism is not unique to peptides—insulin users have understood lipohypertrophy for decades—but it applies directly to any repeated subcutaneous injection.

1. Lipohypertrophy: The Silent Tissue Change

Lipohypertrophy is the clinical term for hypertrophic adipose tissue—overgrowth of subcutaneous fat cells at injection sites. It happens because repeated mechanical trauma and localized inflammation trigger a tissue remodeling response. The result is a firm, thickened area of tissue that can range from subtle to visually obvious.

Why it matters: Hypertrophic tissue has reduced blood flow and different absorption kinetics than normal subcutaneous fat. Insulin studies consistently show 25–50% absorption variability between normal sites and hypertrophic sites. This variability is not unique to insulin—it applies to any compound requiring subcutaneous absorption. If you are running a GH secretagogue stack where timing is critical, injection into hypertrophic tissue can delay onset by 10–20 minutes or reduce peak concentration. If you are running TB-500 or BPC-157 on a twice-daily protocol, absorption variability makes dosing less predictable.

2. Scar Tissue and Fibrosis

Subcutaneous tissue responds to repeated puncture by forming small areas of fibrous scar tissue. This is a natural inflammatory response, but it cumulates. Over months of twice-daily injections at the same site, you are essentially creating a small keloid-like area beneath the skin. Scar tissue is less vascular than healthy adipose tissue, further reducing absorption and creating a mechanical barrier to future injections.

3. Local Immune Response and Granuloma Formation

Repeated injection at the same site can trigger a sustained localized immune response—the tissue “remembers” the trauma. In some cases, this develops into a granuloma (a nodular collection of immune cells). This is rare with sterile technique and modern insulin-like peptides, but it is a documented complication in diabetes literature. The immune response itself increases local inflammation and can further impair absorption.

4. Absorption Inconsistency and Pharmacokinetic Variability

The cumulative effect of lipohypertrophy, scar tissue, and altered local blood flow is absorption inconsistency. You inject 10 mcg of a GH secretagogue into your left abdomen on Monday and it peaks at 45 minutes. You inject the same dose into the same spot on Tuesday and it peaks at 65 minutes because the tissue is now more scarred and inflamed. This variability makes it impossible to dial in your protocol—you cannot tell if a dose is underdosed or if the absorption site is just degraded.

The Evidence Basis

Lipohypertrophy data comes from insulin research, where the problem has been extensively characterized. A 2014 review in Diabetes Spectrum (drawing from multiple decades of insulin-pump and insulin-injection studies) found that 24–70% of insulin users developed lipohypertrophy at their preferred injection sites, and hypertrophic sites showed insulin absorption rates 25–50% lower than normal sites. A 2018 study in Diabetes Care (PMID: 29510590) directly measured insulin absorption from normal vs. hypertrophic adipose tissue and found significant absorption delay and reduced peak concentration at hypertrophic sites.

The mechanism—repeated trauma → inflammation → adipose tissue hypertrophy and fibrosis → reduced blood flow → altered absorption—is tissue-level physiology, not insulin-specific. It applies to any compound requiring subcutaneous absorption, including peptides.

↑ Back to top

The Four Primary Subcutaneous Injection Zones

Subcutaneous tissue exists anywhere you can pinch an inch of skin—which is most of your body. But for self-injection, you are practically limited to sites you can reach, that have reliable fat depth, and that are socially visible enough that you can monitor for problems. The four primary zones are well-defined, accessible, and have enough fat to absorb 0.1–0.5 mL of peptide solution reliably.

Zone 1: Abdomen (Most Common)

Where: The lower abdomen, below your ribs and above your hip bones, extending from just below the navel to the top of the pubic bone, and from one side of the abdomen to the other.

Boundaries (for a 90 kg adult):

• Lateral (side-to-side): About 2–3 inches inward from each hip point. Avoid the area directly over your hip bone itself—not enough subcutaneous fat.
• Superior (top): Approximately 2 inches above the navel. The umbilicus is a landmark; stay below and lateral.
• Inferior (bottom): The natural crease above the pubic region. Avoid the genitalia zone entirely.
• Depth**: Approximately 1 cm (10 mm) of subcutaneous fat in normal-weight individuals. In leaner individuals (low body fat), the abdomen may only have 5–8 mm of fat—pinch to test before injecting.
• Avoid the waistband area. Elastic pressure and constant friction create mechanical irritation that exacerbates lipohypertrophy.

Why the abdomen is preferred: The abdomen has the most consistent subcutaneous fat depth and the highest blood flow of any site. This means fastest and most reliable absorption—10–15 minutes to peak effect for fast-acting compounds like GH secretagogues. For people running a GH secretagogue stack designed for morning rapid onset, the abdomen is the obvious choice.

Dividing the abdomen: You can divide the abdomen into left and right halves, or into four quadrants (left upper, left lower, right upper, right lower). Most people prefer left/right halves for simplicity. If you are rotating every other day, you might inject left abdomen Monday, right abdomen Tuesday, left abdomen Wednesday, and so on.

Zone 2: Outer Thigh (Intermediate Absorption)

Where: The outer surface of your thigh, roughly from hip to knee. This is the lateral (outside) thigh, not the front (quadriceps) or inner (adductor) surfaces.

Boundaries:

• Lateral: The outside edge of your thigh, approximately the midpoint between the front and back of your leg.
• Superior (top): A hand-width below your hip joint.
• Inferior (bottom): A hand-width above your knee.
• Depth: Approximately 0.8–1.2 cm depending on body composition. The thigh is comparable to the abdomen but slightly less consistent.
• Avoid the IT band (the tendon running along the outer thigh near the knee) and the very top of the thigh where it meets the hip—less fat there.

Why the thigh: The thigh is accessible, has reasonable fat depth, and is not exposed (unlike the abdomen). It is an excellent second-choice site. Absorption is slightly slower than the abdomen (15–25 minutes to peak) because blood flow is lower. This is useful if you want to separate your morning rapid-onset dose (abdomen) from an afternoon or evening dose with a slower onset profile.

Dividing the thigh: Left thigh and right thigh are the simplest divisions. You can rotate left/right on a daily or every-other-day basis.

Zone 3: Posterior Upper Arm (Slow Absorption)

Where: The back surface of your upper arm, between the shoulder and elbow. This is the triceps region, not the front (biceps) or sides.

Boundaries:

• Posterior (back): The back third of your arm surface, roughly aligned with your triceps muscle.
• Superior: A hand-width below the shoulder.
• Inferior: A hand-width above the elbow.
• Depth: Approximately 0.8–1.0 cm. The upper arm tends to have less fat than the abdomen, especially in lean individuals. Always pinch to verify depth.

Why the arm: The arm is less vascular than the abdomen, resulting in slower absorption (20–30 minutes to peak). This can be strategically useful—it allows you to separate a morning rapid-onset dose (abdomen) from an afternoon dose with a more gradual profile. The arm is also relatively small in circumference, making it easy to avoid re-injecting in old sites.

Dividing the arm: Left and right arms are the simplest divisions. Some people further divide each arm into upper and lower sections.

A caution about fat depth: The posterior upper arm has less subcutaneous fat than the abdomen or thigh. In lean individuals, it may only have 5–6 mm of fat. Injecting into muscle or subcutaneous connective tissue (fascia) is uncomfortable and affects absorption. Always pinch the skin at your injection site and estimate depth before committing.

Zone 4: Upper Outer Buttock (Slowest Absorption)

Where: The upper outer quadrant of your buttock, roughly where an intramuscular injection would go—but shallower.

Boundaries:

• Upper outer quadrant: Imagine dividing each buttock into four quarters. You inject in the outer upper quarter, away from the centerline and away from the anus.
• Superior: Just below the hip bone/iliac crest.
• Medial (center): The gluteal cleft (center line). Stay at least 2–3 inches lateral to this.
• Depth: Approximately 1–1.5 cm of subcutaneous fat in most individuals, sitting above the gluteus maximus muscle.

Why the buttock: The buttock has substantial fat depth (comparable to the abdomen) but much lower blood flow than the abdomen or thigh. This results in the slowest absorption of all the primary sites—20–40 minutes to peak effect. This can be useful if you want to stagger doses across different absorption profiles (morning abdomen for rapid onset, evening buttock for delayed, sustained effect). The buttock is also the site least likely to be exposed or visible, which some people prefer for privacy.

A practical note: The buttock is harder to access—you may need a small mirror or, practically speaking, to accept that you might not see the injection site directly. This does not make it less safe, but it does require trust in your technique. If you are new to injecting, the abdomen and thighs are easier to control and monitor.

↑ Back to top

Absorption Speed and Why Timing Matters

The four zones have meaningfully different absorption rates, and these differences matter most for timing-sensitive peptides.

The Absorption Hierarchy

Based on insulin literature and extended to peptide use (noting the extrapolation where specifics are not directly measured):

Why This Matters: The GH Secretagogue Example

GH secretagogues (compounds like GHRP-2, GHRP-6, and peptide-mimetic analogs) have a narrow therapeutic window for GH stimulation. The endogenous GH pulse typically occurs 30–60 minutes after secretagogue administration. If you inject a GH secretagogue into hypertrophic abdominal tissue and absorption is delayed by 15–20 minutes, your peak peptide concentration may occur 35–45 minutes post-injection instead of 20–30 minutes. This can mean you miss the window for maximal GH release or capture a smaller portion of the natural GH pulse.

Injecting your morning GHRP dose into normal abdomen tissue (which peaks at 10–15 minutes) versus into your thigh (which peaks at 20–25 minutes) can shift your GH response timing by 10–15 minutes. For most people this is a minor difference. For people optimizing for competitive sleep or athletic performance timing, this matters.

Practical Implication: Site Selection by Dose

For a twice-daily protocol like BPC-157 + TB-500 at 10 mcg each, 2x daily:

• Morning dose: Abdomen (all things equal, get the fastest absorption)
• Evening dose: Thigh or arm (slower absorption is fine for TB-500 and BPC-157, which have wider therapeutic windows than GH secretagogues)

For a GH secretagogue stack (e.g., GHRP-2 10 mcg + CJC-1295 no DAC 100 mcg) designed for rapid GH release:

• Every dose: Abdomen (prioritize fast, reliable absorption)
• Rotate within the abdomen (left/right halves, or quadrants) to avoid lipohypertrophy

For someone running multiple peptides across different times (e.g., GH secretagogue in AM, BPC-157 at lunch, TB-500 in PM):

• GH secretagogue (AM): Abdomen
• BPC-157 (afternoon): Thigh or arm
• TB-500 (PM): Buttock or opposite thigh

This spreads the load across zones and uses each zone’s absorption profile strategically.

↑ Back to top

Rotation Patterns: Clock Method, Grid Method, Zone-Per-Day Scheduling

A rotation system is a deliberate plan for which site you use on which day. The goal is to inject each site no more than once every 3–5 days, giving tissue time to recover between insults.

The Clock Method (Best for Single Daily Injections)

Imagine your abdomen as a clock face, with 12 o’clock at your sternum and 6 o’clock at your navel. Divide the abdomen into 8–12 injection sites using the hour markers (or half-hour markers for more sites).

How to use it:

• Injection 1: 12 o’clock position
• Injection 2: 2 o’clock position
• Injection 3: 4 o’clock position
• …and so on, rotating around the clock.

Advantages:

• Very systematic and easy to remember.
• Ensures you never hit the same site twice in a row.
• Works well for single daily injections.

Disadvantages:

• All injections are in the same zone (abdomen), so you miss the absorption diversity benefits.
• For twice-daily injections, you might return to a site every 4 days instead of every 5+.

The Grid Method (Best for Precision Tracking)

Map your abdomen (or each zone) into a grid—say, 3 columns × 3 rows = 9 sites. Number them:

“ 1 2 3 4 5 6 7 8 9 “

Avoid the center column (directly over your midline/navel) and stick to the lateral areas.

How to use it:

• Week 1: Sites 1, 2, 3, 4, 6, 7, 8, 9 (skip 5, the center)
• Week 2: Rotate to a different zone (thigh, arm, buttock) and use a similar grid
• Week 3+: Cycle back

Advantages:

• Highly organized and easy to document.
• Ensures even spacing of injection sites.
• Works well if you are using detailed tracking (see below).

Disadvantages:

• Requires more upfront planning.
• Only works if you stick to the grid and track carefully.

Zone-Per-Day Scheduling (Simplest for Multi-Injection Protocols)

Rotate through your four zones on a predictable schedule:

Example for twice-daily injections (AM and PM):

This is the simplest method. Each zone is used once every four days. Abdomen is used twice on that day (AM and PM on opposite sides), so it is revisited every 2 days, but different sides—this is acceptable for high-frequency injection protocols.

Advantages:

• Extremely simple to remember and track.
• Ensures you use all four zones regularly, diversifying absorption profiles.
• No written system required if you keep one note (“Monday = abdomen, Tuesday = thigh,” etc.).

Disadvantages:

• Less precise site management within each zone.
• Less useful if you prefer to stay within a single zone (e.g., abdomen-only for GH secretagogue stacks).

Hybrid Approach (Recommended for Most People)

Combine zone-per-day scheduling with left/right or clock subdivision:

This is simple enough to remember, diverse enough to prevent lipohypertrophy, and clear enough to track with a one-line note.

↑ Back to top

How to Track Your Sites

Tracking is the difference between a rotation system on paper and a rotation system you actually follow.

Minimal Tracking (Single Daily Injection, No Protocol Stack)

Write a single note on your phone that you update once per day:

“ Today: Left abdomen Yesterday was right abdomen Tomorrow: Left thigh “

Update it each time you inject. This takes 10 seconds and is enough to stay honest about rotation.

Simple Logging (Twice-Daily Protocol, Single Peptide)

Create a note that you use as a running log:

“ Mon: L abd, R abd Tue: L thigh, R thigh Wed: L arm, R arm Thu: L glute, R glute Fri: L abd, R abd ... “

Copy and paste this schedule each week. Takes one minute per week to maintain.

Detailed Tracking (Multi-Peptide, Multi-Injection Protocol)

If you are running 2+ peptides at different times, track each separately:

“ DATE | TIME | COMPOUND | DOSE | SITE | NOTES Mon | 7am | BPC-157 | 10µg | L abd | OK, small red spot fading Mon | 7pm | TB-500 | 10µg | R abd | OK Tue | 7am | BPC-157 | 10µg | L thigh | OK ... “

This takes 30 seconds per injection but gives you a complete record. If you develop a problem site (bruising, numbness, lump), you can look back and see which compound and dose you were using.

Using a Spreadsheet or App

If you prefer digital logging, a simple spreadsheet works:

• Columns: Date, Time, Compound, Dose, Site, Volume, Appearance (normal/red/bruised/numb), Notes
• Rows: One per injection

Review monthly. Look for patterns (e.g., “left thigh always gets red,” “buttock injections always slower to absorb”).

A note on dedicated apps: there are a few peptide-tracking apps, but a spreadsheet or simple phone note is faster and does not require another account. Use what you will actually maintain.

↑ Back to top

What Lipohypertrophy Looks Like (and When to Skip)

Lipohypertrophy develops gradually. You need to know what to look for, because the early signs are subtle.

Early Signs (Skip This Site for 3–5 Days)

• Firm, slightly thickened tissue under the skin at the injection site. On palpation (feeling with your fingers), the tissue feels harder than surrounding skin. It may be a circle approximately 1–2 inches in diameter.
• Very subtle dimpling or texture change visible only in certain lighting or when the skin is pinched.
• Slight redness that persists beyond 24 hours post-injection. Normal injection redness fades within a few hours to 24 hours. If redness is still present at 48 hours, it indicates local inflammation.

Moderate Signs (Skip This Site for 1–2 Weeks, Consider Dermatology Evaluation)

• Obvious lump palpable beneath the skin, firm to the touch, approximately 1–3 cm in diameter.
• Visible thickening of the tissue layer. The skin at the site looks slightly “puffy” or raised compared to surrounding tissue.
• Persistent redness and warmth at the site. Temperature at the site is noticeably warmer than surrounding skin (mild fever-sign).
• Bruising that spreads beyond the immediate injection site or persists >5 days.
• Mild discomfort or tenderness when touching the area. Not severe pain, but noticeable ache or sensitivity.

Severe Signs (Seek Medical Evaluation, Stop Injecting at This Site Indefinitely)

• Large, hard nodule >3 cm in diameter, possibly with overlying redness, warmth, or drainage.
• Signs of infection: increasing redness, warmth, swelling, pus, fever, or systemic illness (malaise, headache).
• Numbness or tingling at or near the injection site (possible nerve irritation or compression).
• Severe pain on injection or at rest (possible abscess, cellulitis, or neuritis).

Distinguishing Lipohypertrophy from Infection

This is important because the response is different.

If you see signs of infection, seek medical evaluation. Clean the area with antiseptic, do not re-inject at that site, and contact a healthcare provider if fever develops or redness spreads.

If you see lipohypertrophy, skip the site for 1–2 weeks, increase rotation frequency (inject sites you have not used in >7 days), and consider reducing injection frequency at that zone if feasible. Most lipohypertrophy is reversible if you stop re-injecting the affected site.

↑ Back to top

Special Considerations for Multi-Injection Protocols

If you are running a full stack—say, BPC-157 + TB-500 + a GH secretagogue, with multiple daily doses—your rotation system needs extra structure.

The Two-Injection-Per-Day Scenario (Most Common)

Example: BPC-157 + TB-500, 2x daily

“ Day 1: Abdomen L (BPC-157) + Abdomen R (TB-500) Day 2: Thigh L (BPC-157) + Thigh R (TB-500) Day 3: Arm L (BPC-157) + Arm R (TB-500) Day 4: Buttock L (BPC-157) + Buttock R (TB-500) Day 5: Abdomen L (BPC-157) + Abdomen R (TB-500) [cycle repeats] “

This schedule ensures:

• Each abdomen site is used once every 8 days (acceptable for these peptides).
• Both sides are used, preventing unilateral tissue damage.
• You cycle through all zones, diversifying absorption.

Tracking: One note per day saying “Abdomen today, both sides” is sufficient. If a problem develops, you can distinguish which compound caused it (unlikely—both are low-risk) or whether one side always reacts worse.

The Three-Injection-Per-Day Scenario (Advanced Protocol)

Example: GHRP-2 (morning), BPC-157 (afternoon), TB-500 (evening)

Or, simpler: use a different zone for each time-of-day:

Then rotate left/right within each zone on a 2-day cycle:

“ Mon: Abd L (AM), Thigh L (PM), Arm L (Eve) Tue: Abd R (AM), Thigh R (PM), Arm R (Eve) Wed: Abd L (AM), Thigh L (PM), Arm L (Eve) ... “

This is more complex but very clear: each site gets used once every 2–3 days, each compound has a dedicated zone with matched absorption profile, and tracking is straightforward (“left days and right days”).

Tracking: Use a detailed spreadsheet. One row per injection. Columns: Date, Time, Compound, Dose, Site, Volume, Appearance, Notes. Review weekly for patterns.

High-Frequency Protocols (4+ Daily Injections)

This is rare for peptides but possible (e.g., someone running BPC-157 four times daily). At this frequency, you are limited by site availability. You cannot adequately rotate with four daily injections using only the four primary zones. Options:

1. Reduce frequency to 2–3 injections/day if feasible. Most protocols do not require 4+ daily doses.
2. Expand to secondary sites (lower abdomen, inner thigh, hip area, etc.) under medical guidance.
3. Increase injection volume and reduce frequency. Instead of 10 mcg twice daily, consider 20 mcg once daily if peptide kinetics allow. This cuts injection count in half.
4. Seek medical management. If a protocol truly requires 4+ daily injections, it is worth discussing with a healthcare provider who can help plan site rotation, assess tissue, and monitor for complications.

↑ Back to top

How Rotation Interacts with Timing

The timing of your peptide (when you want peak concentration) and the absorption speed of your injection site are not independent variables—they interact.

Synchronizing Timing with Site Selection

GH Secretagogue Protocol (Designed for Pre-Sleep or Pre-Exercise GH Release)

Goal: GH secretagogue peaks 30–40 minutes post-injection, coinciding with natural GH pulse or exercise window.

• Injection time: 60 minutes before desired peak (e.g., 8:00 PM for 9:00 PM peak)
• Site: Abdomen (fastest absorption, 10–15 min peak)
• Result: Peptide peaks at ~8:15 PM, allowing 30–45 min buffer before sleep/exercise at 9:00 PM

If you injected the same compound into your buttock (20–40 min peak):

• Injection time: 8:00 PM
• Peak time: 8:40–8:20 PM
• Result: Peak occurs close to or after your 9:00 PM window, reducing GH response

This is why GH secretagogue users typically stay with the abdomen: the absorption speed is optimized for their timing goal.

BPC-157 / TB-500 Protocol (Wound Healing or Recovery)

Goal: Local accumulation and systemic bioavailability. Timing is less critical than with GH secretagogues.

• Absorption speed matters less because the therapeutic window is wider.
• You can inject in any zone without significantly altering outcomes.
• This gives you freedom to rotate through all four zones without timing concerns.

Mixed Protocol (GH Secretagogue + BPC-157 + TB-500)

• 7:00 AM: GH secretagogue in abdomen (fast absorption, optimized for morning GH release)
• 12:00 PM: BPC-157 in thigh (intermediate, timing flexible)
• 8:00 PM: TB-500 in arm or buttock (timing flexible, evening dosing)

Each peptide goes to the zone matched to its timing requirements and absorption profile.

The Danger: Over-Rotating Away from Your Optimized Site

A common mistake is to rotate your GH secretagogue away from the abdomen out of a zeal for rotation. This is wrong.

Correct approach: Rotate within the abdomen (left side, right side, or using a grid of abdominal sites). Do not move your GH secretagogue to the thigh or arm, because you are trading faster absorption for the sake of rotation. This defeats the purpose.

Correct rotation system for GH secretagogue stacks:

• Every injection: abdomen only
• Rotate: left/right halves, or use a clock/grid system within the abdomen
• Frequency: inject each specific site no more than once every 4–5 days

Correct rotation system for BPC-157/TB-500 stacks (where timing flexibility exists):

• Use all four zones (abdomen, thigh, arm, buttock) on a rotating schedule
• This diversifies absorption and tissue recovery
• No timing penalty because these peptides have wide therapeutic windows

↑ Back to top

FAQ

Related Guides

• Subcutaneous Injection Technique — The mechanical how-to for injecting correctly: needle gauge, angle (45°–90°), and depth verification. Explainer.
• Peptide Reconstitution — Preparing your peptide solution so it remains stable and absorbs predictably. Explainer.
• Managing Adverse Reactions — Redness, bruising, swelling, itching: what is normal, what is a problem, and when to seek care. Explainer.
• Peptide Stacks — Coordinating multiple peptides across different times of day while managing absorption and site rotation. Explainer.

↑ Back to top

Closing Statement

Rotation is not complicated, but it requires consistency. A simple system—one site per day, left/right halves, or a basic phone note—is more effective than a complex system you do not follow. The goal is to keep your tissue healthy and your absorption predictable. Spend 30 seconds per injection updating a note about which site you used today. Your future self, with healthy tissue and consistent peptide response, will thank you.

—

—

This guide is part of the Peptidings how-to series. It is written for readers with access to pharmaceutical-grade peptides and basic subcutaneous injection skills. It is not a substitute for professional medical guidance.

↑ Back to top

---